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2ABSTRACT
The 20 residue long Trp-cage miniprotein is an excellent model both for computational and 
experimental studies of protein folding and stability. Recently, a great attention emerged to study 
disease-related protein misfolding, aggregation and amyloid formation, with the aim of revealing 
their structural and thermodynamic background. Trp-cage is sensitive to both environmental and 
structure-modifying effects, and aggregates with ease upon structure destabilization and thus, it 
is an ideal model of aggregation and amyloid formation. Here, we characterize the amyloid 
formation of several sequence modified and side-chain phosphorylated Trp-cage variants. We 
applied NMR, CD, FTIR spectroscopy, MD simulations, transmission electron microscopy in 
conjunction with thioflavin-T fluorescence measurements to reveal the structural consequences 
of side-chain phosphorylation. We demonstrate that the native fold is destabilized upon serine 
phosphorylation and the resultant highly dynamic structures form amyloid-like ordered 
aggregates with high intermolecular β-structure content. The only exception is the D9S(P) 
variant which follows an alternative aggregation process by forming thin fibrils, presenting a CD 
spectrum of PPII helix, and showing low ThT binding capability. We propose a complex 
aggregation model for these Trp-cage miniproteins. This model assumes an additional 
aggregated state, a collagen triple helical form which can precede amyloid formation. The 
phosphorylation of a single serine residue serves as a conformational switch, triggering 
aggregation, otherwise mediated by kinases in cell. We show that Trp-cage miniprotein is indeed 
a realistic model of larger globular systems of composite folding and aggregation landscapes and 
helps us to understand the fundamentals of deleterious protein aggregation and amyloid 
formation. 
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INTRODUCTION
Increasing number of diseases are linked to amyloid aggregate formation, occurring seemingly 
independently of the amino acid sequence.1 Apart from the disease-related amyloids, some 
functional amyloid proteins has also been discovered which play an important role e.g. in 
melanin synthesis or in bacterial biofilm formation.2 Other studies suggested that the amyloid 
aggregate state might represent the global energy minimum in the folding process of many native 
proteins3, therefore the investigation of the amyloid protein structures and the mechanisms 
through they are formed is of fundamental importance. 
The main structural characteristic of amyloid aggregates are the strongly H-bonded cross-β 
structure where the β-strands are oriented perpendicular to the fiber axis (e.g. in amyloid-β, 
IAPP, α-synuclein, Huntingtin).4,5 These β-strands can be parallel or antiparallel, in-register or 
out-of-register depending on the protein’s primary sequence.4,6 From a mechanistical point of 
view, the oligomerization is initiated by specific sequences through yet unknown intermediate 
states which then mature into toxic aggregates of various morphologies and further into plaques, 
deposits and tangles.7,8 Much more is known about their macroscopic structure, pathologic 
description and diagnostic epitopes, but the mechanistic details of the process which leads to 
amyloid formation is still unclear at the molecular and atomic level.
The role of posttranslational modifications (such as truncation or phosphorylation) in 
amyloidoses and the underlying molecular pathomechanism is poorly understood.9-12 There is 
increasing evidence that abnormal- or hyperphosphorylation might be the driving force in the 
intracellular aggregation of tau protein13,  α-synuclein14-20 and amyloid-β peptide.21-25 The 
4phosphorylation at specific Ser or Thr residues might promote the nucleation-dependent 
oligomerization and thus aggregation of these proteins by increasing the β-sheet character of the 
modified sequences.21 However, it remains unclear to what extent is the secondary structure 
affected and how the inter- and intramolecular interactions are modified due to the side-chain 
phosphorylation.
Therefore we aimed to study the aggregation process of a model system (Trp-cage) 
phosphorylated at different Ser side chains to gain insights into the mechanistic and atomic 
details of amyloid aggregate formation. Trp-cage is the smallest protein-like molecule which 
could realistically model larger globular proteins or domains.26 It consist of only 20 residues but 
still folds into a well-defined tertiary structure26 through a complex folding pathway.27 Due to its 
small size it is an excellent model system for both experimental26, 28-32 and computational 
studies.33, 34 Recent studies however focus mainly on the native structure, folding and stability of 
the system while none of them investigates intermolecular interactions which could lead to 
oligomerization or aggregation of Trp-cage.
Here we present a mechanistic insight into the aggregation processes of different Trp-cage 
variants. Using various spectroscopic methods we have tested how the phosphorylation of 
specific serine side chains induces conformational switches and thus initiates native to amyloid 
fibril formation. We have synthesized and purified three Ser-PO4H2-derivatives of Trp-cage (Fig. 
1), namely that of Tc5b_13S(P), Tc5b_14S(P), and Tc5b_20S(P). In addition, the intramolecular 
salt bridge forming D9 of Tc5b was altered and thus, Tc5b_D9E, Tc5b_D9S and Tc5b_D9S(P) 
were also synthesized and studied (short names presented in Fig. 1 will be used throughout the 
manuscript). The secondary structure contents of the monomer and aggregated forms were 
monitored using NMR chemical shift deviations, and Circular Dichroism (CD) and Fourier 
5Transform Infrared (FTIR) spectroscopy. The amyloid properties and morphologies of the 
aggregates were studied by thioflavin-T (ThT) fluorescence and transmission electron 
microscopy (TEM).
Figure 1. (Left) Amino acid sequences of Trp-cage variants. The secondary structure composition in the 
“native” form of Trp-cage is indicated at the top. (Right) Backbone scheme of the 3D-fold of a typical 
Trp-cage composed of an α- and a 310-helix, terminated by the proline rich segment in PPII-like 
conformation as determined by NMR spectroscopy.26, 29 We use the short names of Trp-cage variants 
throughout the text as follows: Tc5b_D9E, D9E; Tc5b_D9S, D9S; Tc5b_D9S(P), D9S(P); 
Tc5b_S13S(P), 13S(P); Tc5b_S14S(P), 14S(P); Tc5b_S20S(P), 20S(P).
MATERIALS AND METHODS
Peptide synthesis and purification. Peptides were synthesized by solid-phase technique 
utilizing Fmoc chemistry as described previously.29 Phosphopeptides were prepared by the 
standard global method; serine residue to be phosphorylated was built into the sequence without 
side-chain protection. Phosphorylation was carried out after the assembly of the peptide chain on 
the solid phase by the phosphoramidite method.35 The crude peptides were purified by semi-
preparative RP-HPLC. Detailed procedure of peptide synthesis and purification is presented in 
Supporting Material.
Dissolution of Trp-cage samples and aggregate formation. Peptide samples were dissolved 
in H2O at a concentration of 2-10 mg·ml
-1. The pH was measured by a NOP-0823P 
microelectrode (Radelkis, Budapest, Hungary) and adjusted to ~7.0 adding small aliquots of 0.1 
6M NaOH. FTIR experiments were carried out in D2O. Although we avoided using buffer 
compounds, the protonable groups of the peptides at the relatively high concentration assured a 
stable pH. Aggregates were prepared by two days incubation at 37 °C in a shaker. Differently 
from the other peptides, D9S(P) became viscous only at low temperature upon storing in 
refrigerator. For concentration measurements the samples were diluted in 6 M guanidium 
chloride. Peptide concentration was determined by the absorbance at 280 nm using an extinction 
coefficient of 6990 M-1·cm-1.
NMR Spectroscopy. All NMR spectra were acquired on a Bruker DRX700 spectrometer 
(Bruker Corp., Germany) equipped with 5 mm triple resonance probe on peptide samples of ~1 
mM concentration at 6.5 < pH < 7.1 (10% D2O and DSS as the internal proton reference standard 
set to 0 ppm) at 288 K. 1H-1H TOCSY, 1H-1H COSY and 1H-1H NOESY spectra were recorded 
(65 ms < spinlock time < 80 ms, and 100 ms < mixing time < 300 ms) to assign the chemical 
shifts. The chemical shift deviations were calculated using published method with random coil 
values36 used in other studies of Trp-cage miniproteins.28, 37 CSDcage was derived from the sum of 
the absolute CSD values of the following protons: W6Hε1, L7Hα , G11Hα2, P12Hβ2, R16Hα , 
P18Hα , P18Hβ2, P19Hδ1 and P19Hδ2, CSDhelix was derived from the CSDs of Y3Hα, Q5Hα, W6Hα 
and K8Hα.
Transmission electron microscopy. Samples were diluted 20-fold with water and applied to 
300-mesh formvar/carbon-coated copper grids, allowed to adhere for 1 min, and stained for 40 
sec with 1% uranyl acetate. Grids were examined by a JEOL 100 CX II transmission electron 
microscope (JEOL Ltd., Tokyo, Japan) at an accelerating voltage of 60 kV.
Circular dichroism spectroscopy. CD measurements were carried out on a Jasco J-715 
spectropolarimeter (Japan Spectroscopic Co., Tokyo, Japan) in Hellma quartz cells of 0.01, 0.1 
7(250-190 nm region) or 1 mm pathlengths (310-240 nm region) (Hellma GmbH, Müllheim, 
Germany) using a Peltier-thermostated cell holder. CD spectra were recorded at a scanning speed 
of 10 nm/min in continuous mode using 1 nm bandwidth and accumulated 3 times. Monomer 
samples were spun down at 120000g for 30 min in a TLA-100 ultracentrifuge (Beckman 
Coulter Inc., Fullerton, California, USA) before measurements to remove any aggregate 
contamination. The spectrum of the aggregated material was produced as the difference between 
the spectrum of the total sample and that of its supernatant after 30 min centrifugation at 
120000g. The experiments were repeated 2-4 times and representative spectra were shown. 
The secondary structure composition was estimated by the GlobalWorks (Olis Inc., Bogart, GA, 
USA) software package.
Thioflavin-T (ThT) fluorescence measurements. ThT fluorescence was monitored at 485 nm 
with excitation at 445 nm using a SPEX Fluoromax instrument (Spex Industries Inc., Edison, 
N.J., USA) as described by Naiki et al.38 5 nm excitation and emission slits were used. 5 μl 
aliquots of the protein samples were added to 1 ml assay buffer containing 5 μM ThT in 50 mM 
glycine, 100 mM NaCl, pH 8.5 at 25 °C, and the fluorescence intensity was recorded with no 
delay. Measurements were carried out in triplicates. The measured intensities of the different 
samples were normalized to equal protein concentrations. In the used concentration range the 
ThT fluorescence intensity was proved to be linear to the protein concentration (data not shown).
Fourier-transform infrared spectroscopy. Infrared spectra of Trp-cage peptides at ~10 
mg·ml-1 concentration were measured on a Bruker IFS28 FTIR spectrophotometer (Bruker 
Corp., Germany). CaF2 cell with 100 μm pathlength was used in water-jacketed cell holder. 
Temperature was controlled by a Techne TU 16D thermostat, with the actual temperature 
measured by a sensor attached directly to the CaF2 cell window. Protein concentration of 5-10 
8mg/ml was relatively low for FTIR measurements, thus the experiments were carried out in D2O 
to avoid the high absorbance of H2O in the amide I region (at around 1650 cm
-1). pD was defined 
as pD = pD* + 0.4, where pD*, the pH meter reading in D2O, is corrected for the isotope effect. 
128 scans were accumulated in the 400–4000 cm-1 region with 1 cm-1 resolution. To avoid the 
contribution of water vapor peaks to the spectra, the instrument was purged with N2. All spectra 
were corrected with D2O baseline. The HPLC purified and lyophilized peptide samples 
contained trace amounts of trifluoro-acetic acid (TFA), which resulted a sharp peak at 1672 cm-1
in the IR spectra. This peak was eliminated by the subtraction of a TFA spectrum with 
appropriate ratio. Monomer samples were spun down at 120000g, 30 min in a Beckman TLA-
100 ultracentrifuge before measurements. The spectrum of the aggregated material was produced 
as the difference between the spectrum of the total sample and its supernatant after 30 min 
centrifugation at 120000g.
Model building and molecular dynamics (MD) simulation of polyproline II helix. The 
collagen triple helix X-ray structure of the [(Pro-Pro-Gly)10]3 peptide
39 (1k6f.pdb) was used as a 
template structure for modeling a polyproline II helix that is formed as a polymer of D9S(P) 
molecules. The initial structure of the proline-rich C-terminal part of D9S(P) was built up with 
all possible Pro-Pro-Gly frames by adjusting the corresponding backbone φ, ψ angles to those of 
the template molecule. The triple helix was constructed from the initial structure using four 
D9S(P) molecules per chain (12 molecules for the three collagen chain) and applying a shift 
between the collagen chains for necessary overlap to produce a stable polymer. Because only the 
C-terminal half of the Trp-cage is compatible with the collagen structure, the N-terminal, 
“hanging” part needs a space (gap) corresponding to two residues in the collagen chain for the 
clash-free turning out from the triple helix. Models were refined by the UCSF Chimera program 
9package40 using an AMBER force field41 in vacuum. The obtained model of D9S(P) was used to 
derive another variant with the phosphate group of Ser9 partially protonated (with a single 
proton, resulting in a group with net charge of -1), which we will denote as D9S(Pp) and the D9S 
variant. The three different models were subjected to molecular dynamics simulations (MD) as 
implemented in GROMACS42, using the AMBER-ff99SBildn forcefield43 using the 
parametrization of Steinbrecher et al.44 for the phosphate moiety. Systems were solvated by 
approximately 13000 TIP3P water molecules, the total charge of the system was neutralized and 
physiological salt concentration set using Na+ and Cl- ions. Energy minimization of starting 
structures was followed by sequential relaxation of constraints on protein atoms in three steps 
and an additional NVT step (all of 200ps) to stabilize pressure. Trajectories of 40ns NPT 
simulations at 279K and 1bar were recorded for further analysis (collecting snapshots at every 
4ps). The original D9S(P) model and the D9S variant reached a stable conformation in 40ns, 
while in case of the D9S(Pp) model, convergence in the same time span was not certain, so that 
system was allowed a run time of 80ns, during which, however D9S(Pp) did not evolve further 
(see Supporting information) – thus the states reached by 40ns could be universally be used for 
comparison purposes. Clustering of conformations45 was carried out based on the backbone 
conformation of each snapshot using a cutoff of 3.0Å.  In figures the mid-structures of the most 
populated clusters (accounting for at least 95% of all snapshots of the last 10ns) of three 
simulations are shown.
RESULTS AND DISCUSSION
The Trp-cage variants (Fig. 1) were incubated for two days at 37 °C in a shaker at 2-5 mg·ml-1
concentration resulting in most of the cases viscous, aggregated solutions. Importantly, the 
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aggregation occurred at neutral pH spontaneously with no use of any additives or co-solvents. 
Tc5b and D9E samples showed large amount of white precipitates. The solution of D9S was 
opalizing and became viscous, while 13S(P), 14S(P) and 20S(P) samples became gel-like and 
remained fully transparent. Unlike other peptides, D9S(P) became viscous only at low 
temperature (4 °C) upon storing in refrigerator with the solution remaining transparent.
Trp-cage sequence analysis for amyloidogenicity
We examined the sequences of the Trp-cage variants for aggregation propensity and 
amyloidogenicity using most of the available predicting algorithms. The region from residue 2 to
7, as a consensus, was predicted to have amyloidogenic propensity (for the list of the algorithms 
and results see Fig. S1). In the case of the phosphorylated variants, none of the algorithms were 
able to handle the Ser(P) side-chain, thus it was replaced with glutamic acid. While the various 
methods provided different results, there were no significant differences between the Trp-cage 
variants. The region 2-7 is exactly overlapping with the position of the α-helix in the native Trp-
cage molecule suggesting that a significant unfolding is a prerequisite for conversion to an 
amyloid structure.
Monomer structures from NMR chemical shift deviation (CSD). The relative stability and 
secondary structure content of the Trp-cage monomers were compared using the same approach 
as used in other Trp-cage folding studies28, 37 CSDcage and CSDhelix values were derived from 
the observed chemical shifts and the random coil values36 to measure the extent of cage and helix 
formation among the different variants. The values revealed that introduction of the bulky and 
negatively charged phosphate group on the serine side-chains substantially decrease the overall 
fold stability; the folded fractions changed from ~90% to ~40% (D9S(P) or 13S(P) or even 
further to ~5-10% (14S(P) or 20S(P)) indicating that at position 9 and 13 the serine 
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phosphorylation is moderately tolerated while at position 14 and 20 it is more destabilizing 
(Table 1). In Trp-cage, the side-chains of Ser13 and Ser20 are completely solvent exposed while 
Ser14 is buried and it forms H-bond with the salt-bridging residues28, 30, therefore the mutation of 
Ser13 and Ser20 should be less destabilizing than the mutation of Ser14. Interestingly, 20S(P) 
was even less stable than 14S(P) which indicates that the steric hindrance and the electrostatic 
repulsion between Tyr3 side-chain and the phosphoserine group at position 20 undermine the 
structure of Trp-cage.  At position 9 the phosphoserine moiety is somewhat tolerated since it 
does not differ substantially in size and charge from aspartate, therefore the CSDcage and 
CSDhelix values are the highest here among the studied variants. Moreover, in the spectra of 
D9S(P) and 13S(P) we observed one and three additional minor conformers, respectively which 
displayed somewhat different overall structures. However, due to heavy peakoverlaps only 
partial assignment was achievable for the minor forms. No sign of minor conformers were 
detected in the spectra of 14S(P) or 20S(P).
Table 1. Residual folding and α-helix propensities of the four Tc5b_xS(P) derivatives at 288 K. 
Peptide CSDcage (ppm)
a CSDhelix (ppm)
a χcageb χhelixb α-helix (%)d
Tc5b 10.17a 1.76a 0.89 0.86 35c
Tc5b_D9S(P
)
1.63 1.16 0.44 0.45 23
Tc5b_13S(P) 4.07 0.99 0.36 0.34 20
Tc5b_14S(P) 0.76 0.63 0.05 0.18 12
Tc5b_20S(P) 0.50 0.57 0.05c 0.05c 11
aCumulative chemical shifts of selected resonances (for details see Table S2) to characterize both the 
Trp-cage fold and the α-helical secondary structural element. bCage and helix fractions.  cUnfolded 
reference and doverall α-helix percentages.
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Secondary structure studied by CD spectroscopy. Figure 2A shows the representative CD 
spectra of the monomers and aggregated forms of different Trp-cage variants. Monomer, native 
form of D9E and D9S mutants show helical structure, as reported previously.26,29,30 All the 
phosphorylated mutant monomers proved to be disordered exhibiting spectra similar to that of 
D9E at 60 °C (Fig. 2A and Fig. S2). The spectra of the aggregated D9E, D9S and 13S(P) variants 
suggest dominantly β-sheet structures (Fig. 2A) and are similar to those reported for amyloid 
fibrils.46-49 In case of D9E, the amplitude is relatively low which might be explained by the 
presence of significant amount of precipitated material with large aggregate particles. Some 
precipitates were also observed in the D9S aggregated sample, while aggregated 13S(P) was 
fully transparent showing a spectrum typical of amyloid fibrils. 
Figure 2. CD spectra and TEM images of the Trp-cage aggregates. (A) CD spectra of the monomer (——) and 
aggregated Trp-cage variants (——) at 9 °C. The aggregated materials were prepared by two days incubation at 37 
°C, except that of D9S(P), which was incubated at 4 °C. For D9E, a disordered spectrum recorded at 60 °C is also 
presented (——). (B) TEM images of the fibrillar aggregates of Trp-cage variants. In case of D9E, white boxes 
indicate associated fibrils exhibiting clear helical twist and are enlarged at the bottom.
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D9S(P) showed only a minor fraction of aggregated material after incubation at 37 °C (Fig. 
S3). However, differently from the other Trp-cage variants, it formed significant amount of 
aggregated material after incubation in the refrigerator at 4 °C. Intriguingly, its CD spectrum was 
different from all others, exhibiting an unusual profile with a positive maximum at 227 nm and a 
minimum at around 208 nm. This spectrum resembles to the spectra of polyproline II helices, 
proline-rich peptides, or left-handed triple helices of collagen.50,51 This finding is further 
supported by the fact that the C-terminal half of the Trp-cage is rich in proline residues. 
Although this PPII-type spectrum can be found even in the monomer state of proline-rich 
peptides, it is important to note that in the case of D9S(P), it was the polymerized material which 
exhibited this unique spectral profile raising the probability that matured triple helix is formed. 
Morphology of the Trp-cage aggregates studied by transmission electron microscopy.
TEM images displayed long, unbranched fibrils with variety in length, diameter and morphology 
(Fig. 2B). In the case of D9E, some thin fibrils with diameter of 2.3 ± 0.3 nm were observed 
which might represent single individual protofilaments. Main portion of the fibrils exhibited an 
average diameter of 4.4 ± 0.3 nm probably consisting of two protofilaments. We could also see 
thick fibrils of complex morphology consisting of several protofilaments exhibiting clear helical 
twist with a periodicity of 30-35 nm as highlighted by white rectangles in the panel of D9E in 
Figure 2B. D9S fibrils formed bundles as thick as 100-200 nm. This lateral association of fibrils 
might be explained by the absence of the charge on the 9th side chain, which can otherwise have 
a repulsive electrostatic effect. 13S(P) formed long, straight, individual fibrils typical of amyloid 
fibrils. In the case of D9S(P), the appearance of the aggregates were different from all the others: 
we observed long, thin (2.5 ± 0.3 nm) and curved fibrils which did not form any bundles.
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Amyloid specific thioflavin-T fluorescence. The formation of amyloid-like aggregates of 
Trp-cage variants was verified by the amyloid specific fluorescent dye, thioflavin-T (ThT).38
Monomer samples showed no ThT fluorescence. The aggregated samples showed high ThT 
fluorescence intensity indicating the presence of amyloid conformation with the exception of the 
D9S(P) variant (Fig. 3). D9S(P), after incubation at 37 °C, showed marginal ThT fluorescence 
intensity with low amount of aggregated material indicating that the phosphorylation of Ser9 is 
unfavorable for amyloid formation. After incubation at 4 °C, we observed a large amount of 
aggregated material, however, with still negligible ThT fluorescence intensity (Fig. 3). This 
suggests that the structure of the majority of D9S(P) aggregates is non-amyloid.
Fig. 3. ThT fluorescence intensity of the aggregated Trp-cage variants. All aggregated samples showed 
high ThT fluorescence intensity indicating the presence of amyloid conformation except that of D9S(P).
Structural comparison by FTIR spectroscopy. The secondary structure content of the 
monomer and aggregated Trp-cage variants was further studied by FTIR spectroscopy, which is 
a suitable technique for investigating opalizing and precipitated samples. The amide-I vibrational 
band (1600–1700 cm-1), dominated by the CO stretching of the peptide bond, is sensitive to the 
secondary structure of the polypeptide chain. IR spectra of the Tc5b, D9E, and D9S monomers 
showed spectral features characteristic of a helical structure with the main component around 
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1643-1645 cm-1. The monomer forms of phosphorylated D9S(P), 13S(P), 14S(P) and 20S(P) 
variants exhibited disordered structures with spectral maximum at ~1640 cm-1 (Fig. 4A). IR 
spectra of the different aggregated forms displayed spectral components significantly different 
from that of the monomers, exhibiting sharp bands at lower wavenumbers (Fig. 4B). After two 
days incubation at 37 °C, the aggregates of Tc5b, and the variants D9E, D9S, 13S(P), 14S(P) and 
20S(P) exhibited amide-I bands at 1613 and 1624 cm-1 indicative of the presence of 
intermolecular β-sheet structure (Fig. 4B).52-55 D9S(P) aggregates showed two sharp peaks at 
1613 and 1629 cm-1 with a broader shoulder around 1650 cm-1 with ratios different from that of 
the peaks of the other two-days aggregates suggesting the presence of a different secondary 
structure (Fig. 4B, C). Bryan et al. carried out FTIR measurements and simulations on collagen 
model peptides such as (Pro-Pro-Gly/Ala)10 and assigned the component at 1629 cm
-1 mainly to 
vibrations of the amide carbonyls located between two prolines in a triple helical conformation.56
Although D9S(P) has a more diverse amino acid composition than the simple Pro-Pro-X model 
peptides, the 1629 cm-1 peak is clearly manifested.
Intriguingly, we could observe the maturation of the 13S(P) and 14S(P) aggregates in the FTIR 
experiments. After dissolving these two peptides, the spectra of their early aggregates were 
found to be different from those of the samples incubated for two days at 37 °C and, rather, they 
reminded of the spectrum of D9S(P) aggregates in the position and ratio of the components (Fig. 
4C). This observation suggests that at high peptide concentration (~10 mg·ml-1), a fast forming 
intermediate polymer emerges, which is converted to amyloid fibrils on a longer time-scale. This 
conversion is not observed for D9S(P), where the phosphorylation of Ser9 traps the conformation 
in the “early” state.
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Figure 4. FTIR detected amide-I vibrational 
bands of Trp-cage variants. (A) IR spectra of 
monomers show spectral features of either 
helical (1643-1645 cm-1) and/or disordered 
(~1640 cm-1) structures. (B) Unlike D9S(P), 
IR spectra of the different aggregated forms 
have typically two sharp bands (1613 cm-1
and 1624 cm-1), attributed to β-strands. The 
aggregate of D9S(P) exhibits amide-I bands 
at 1613 and 1629 cm-1. (C) Maturation of 
13S(P) amyloid fibrils in “two-steps”: after 
dissolving 13S(P), the spectrum of an “early” 
aggregate reminds to that of D9S(P) 
aggregates and is different from the one 
recorded after two days incubation.
D9S(P) and early aggregates of 13S(P) and 14S(P) exhibit PPII helix structure. Compared 
to the aggregates of other Trp-cage variants, D9S(P) exhibited some unique features. It formed 
thin flexible fibrils with negligible ThT binding capacity. Moreover, its CD spectrum was 
reminiscent of a polyproline II helix and FTIR also pointed out clear structural differences. 
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Taking into account that the C-terminal half of the protein is rich in Pro residues (Fig. 1), these 
results suggest that D9S(P) forms a collagen-like PPII structure instead of the cross-β-sheet of 
amyloid fibrils. To verify the feasibility of this hypothesis we have built a PPII triple helical 
polymer model for this peptide. The collagen triple helix X-ray structure of the [(Pro-Pro-
Gly)10]3 peptide (1k6f.pdb) served as a template. We have tried to assemble all possible filament 
constructions. Only one solution resulted in extended H-bonded architecture with no steric 
clashes while all other arrangements showed either severe steric clashes or the lack of essential 
stabilizing interactions. In the lowest energy solution, every chain of the polyproline triple helix 
model is built from the repetitive unit containing the C-terminal ten residues of the peptide in a 
PPII conformation and a two-residue space (gap) for the clash-free turning out of the N-terminal 
part from the collagen chain. This results in a 12 residue long periodicity within the 
nanostructure. A shift of 4 residues between the collagen chains was applied to reach sufficient 
and symmetrical overlap between the monomers to provide a stable H-bonded polymer. In this 
model, 70% of the H-bonds of a collagen triple helix are formed. It is intriguing how the C-
terminal half of Trp-cage can adopt the triple helix conformation. The 12 residues 
PPGPPGPPGPPG repeat of ideal collagen sequence is replaced by the --GPSSGRPPPS 
sequence starting with the two vacancies that is necessary for the turning out N-terminal part of 
the molecule and followed by the Gly11-Ser20 C-terminal half of Trp-cage. 8 positions are 
identical or fully compatible with the ideal sequence. The bulkier side chains at the remaining 
four positions are all compensated by a vacancy on the neighboring collagen chain or pointing 
outwards, such as Arg16 in the position of a proline. In addition, intermolecular Arg16-Ser(P)9
salt-bridges arose between the collagen chains which might be a key event in oligomer 
stabilization (Fig. 5). The distance between the Arg and Ser(P) groups is 2.6-2.7 Å indicating a 
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strong interaction. Besides providing stability, such specific interactions lock the register of 
“sticky-ends” and enable the self-assembly of these shorter peptides to longer triple-helical 
fibers. The diameter of the triple helix is consistent with that of the D9S(P) filaments observed 
by TEM. We have to note that D9S(P) fibrils are stable at low temperature. The replacement of 
the prolines in the collagen consensus sequence with other natural amino acids usually results in 
significant destabilization. 
Figure 5. Starting model of D9S(P) filaments. Residues 4-20 of each molecules are shown. (A) A 
fragment of the PPII triple-helix fibril; red, green and blue stand for the three chains forming collagen-
like structure. (B) View of the triple helix from its main axis. (C) A monomer subunit and its interactions 
in the triple helix. H-bond pattern is depicted by red. The side chains forming Arg16-Ser(P)9 salt bridges 
are presented with ball and stick. 
MD simulations were carried out to ascertain the stability of the created model, and to test the 
effect of partial protonation of the Ser9-phosphate (as a model of shifting the pH to lower values) 
and its complete removal.  Since a self-repeating unit that could be used (with periodic boundary 
conditions) to create an infinite fibril would be a 48-mer of the 20 amino acid-long monomer 
units, the simulation of which is out of the scope of this work, a 12-mer model was considered on 
19
its own instead. This model, however, lacks the stabilization that would arise from forming a 
long-range ordered structure. Nevertheless, the overall topology of the model created by us was 
upheld in the low temperature MD simulations. As it can be seen both in the structure obtained 
from the calculation (Fig. 6A) and the observed decrease of the radii of gyration (Fig. 6B), 
protonation of the S9-phosphate group (D9S(Pp)) or its removal (D9S) resulted in the 
destabilization of the fibril-like structure.  The number of the Arg16-Ser(P)9 H-bonds decreased 
accordingly – of the 11 possible such linkers along the 12-mer of the calculations - 8 Arg16-
Ser(P)9 H-bonds were found in snapshots of D9S(P), while 3-5 in case of D9S(Pp) (with an 
average value of 4.5 ± 0.5) and 0-2 in case of D9S (with an average value of 0.2 ± 0.4). 
Figure 6. MD simulations on the collagen triple helix model. (A) Structures of D9S(P), the partially 
protonated D9S(Pp), and D9S triple helices after MD simulation. (B) The change of the radii of gyration 
during MD simulation, and (C) rmsd compared to the starting model. The simulation for D9S(Pp) was 
extended with another 40 nsec, which part is presented by shifting back to the 0-40 nsec range (magenta).
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In line with our findings, charge pairing between aspartates and lysines of adjacent chains lead 
to high stability triple helix formation in heterotrimers of highly substituted short peptide 
sequences.57 Long, collagen-like fibers of short model peptides have been described by Kotch 
and coworkers in which the three strands are held in a staggered array by disulfide bonds.58
pH dependence of the aggregation of D9S(P) and 13S(P) Trp-cage variants
Investigation of the pH dependence of the aggregation provided an opportunity to test the 
Arg16-Ser(P)9 charge pair suggested by the triple helix model of D9S(P). Phosphoserine side-
chains have one pKa value around 2 and a second pKa around 6 when they lose a second
proton.59 At pH 7 used in our study, the phosphorylated side-chains are double negative. At 
lower pH, such as 4, the D9S(P) variant has charges that are similar to that of the normal Trp-
cage, Tc5b, at pH 7, with a single negative charge on the 9th side-chain. We compared the 
aggregation properties of D9S(P) and the amyloid forming 13S(P) variant at pH 4 and pH 7. We 
measured the thioflavin-T fluorescence, the far-UV CD spectra and determined the amount of the 
aggregated material by ultracentrifugation. 13S(P) variant showed amyloidogenicity at both pHs 
with high thiflavin-T fluorescence intensity and significant amount of aggregated material. At 
pH 4, the strongly aggregating 13S(P) fibrils precipitated out of the solution which made the 
correct CD measurements impossible, while at pH 7, the characteristic β-sheet like CD spectrum 
was manifested (Fig. S4). In contrast, D9S(P) at pH 4 did not show any sign of aggregation when 
incubated either at 37°C or at low temperature for a week. The ultracentrifugation experiment 
showed no spinnable material and the CD spectrum has not changed at the least. In the case of 
D9S(P) at pH 7, CD spectra indicated the presence of the characteristic PPII state with high 
amount of polymerized material and low thioflavin-T binding affinity (Fig. S4). The observed 
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pH sensitivity of D9S(P) aggregation is consistent with the likely loss of the Arg16-Ser(P)9 salt 
bridge at pH 4. At pH 4, where the charges of the molecule are similar to that of the native Trp-
cage (Tc5b) at pH 7, we could expect the amyloid formation of D9S(P). However, this is not the 
case, which suggests that the bulky phosphate group at position 9 destabilizes the amyloid form. 
Indeed, it is very close to the hypothetic end of the β-strands (at residues 7 or 8) in the amyloid 
fibrils predicted from the sequence by various methods (Fig. S1).
To further verify that 9S(P) forms unique polymer structure, we also measured and compared 
the near-UV CD spectra of different forms of 9S(P), 13S(P), and the native, α-helical Trp-cage. 
Although we cannot infer site specific structural information from the near-UV CD of the 
aromatic side-chains, it is sensitive to any conformational changes and works as a fingerprint. 
The near-UV CD spectrum of 9S(P) aggregates were different from that of all other monomer 
and amyloid forms (Fig. S5).
Trp-cage conformations and aggregation mechanism. Today, protein folding research is 
also focusing on protein misfolding and aggregation due to its disease-related importance.60 In 
the present work, we show that Trp-cage miniproteins are capable of forming different 
aggregates including amyloid fibrils at physiological pH at elevated concentrations. However, 
this concentration is similar to that reported to be essential for amyloid formation of the 
GNNQQNY core segment of yeast prion Sup35.61 Using different mutants and phosphorylated 
serine variants, we gained site-specific information on the structure of the different forms of Trp-
cage and we could outline the aggregation mechanism. The CD and NMR results revealed that 
the phosphorylation of any of the serine residues destabilizes the native structure leading to a 
highly dynamic disordered chain (Table 1 and Fig. 2). The effect of phosphorylation is often 
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mimicked in molecular biology with aspartate or glutamate residues as substitutes. However, this 
is not applicable here, as D9E has a stable native like 3D structure29, while in its pair, D9S(P), a 
loss of the α-helical structure is observed. Analyses of CD and FTIR data revealed that the 
structure of any of the aggregated forms of Trp-cage variants lack α-helical conformation 
indicating that aggregates have strikingly different secondary structures. Thus, aggregation 
occurs via partial or complete unfolding of the native state. This hypothesis is supported by the 
fact that the “natively unfolded” 13S(P), 14S(P) and 20S(P) variants easily polymerize into 
amyloid fibrils. On the contrary, D9S(P) fibers exhibit unique, collagen triple-helix-like spectral 
and structural properties stabilized by intermolecular Ser(P)9-Arg16 salt bridges. Besides, β-
strand aggregation of peptides and proteins can also occur via collagen-like triple helix 
multimerization as foreseen by theoretical calculations some years ago.62 Intriguingly, we found 
that early aggregates of 13S(P) and 14S(P) show infrared spectra similar to that of D9S(P) fibers 
(Fig. 4C) suggesting that collagen/PPII helix might be an intermediate structure on the route of 
amyloid fibril formation. While the PPII like backbone structure (with (φ, ψ) backbone dihedral 
angles around (-75°,+145°)) of residues 11-20 was retained in monomers in the low temperature 
MD simulations of D9S(P), D9S(Pp) and D9S (Fig. S6), the collagen helix-like association of 
these monomers was only stable in case of D9S(P). Due to its favorable salt-bridge motif and 
possible steric hindrance in the amyloid state, the D9S(P) variant gets trapped in this 
intermediate, pre-amyloid form. In the absence of such interactions, monomers can progress to 
forming β-sheet type aggregates. The role of the collagen-like aggregate state in amyloid 
formation might be the increase of local concentration promoting further intermolecular 
interactions such as the structural conversion to amyloid fibrils. Similar phenomenon was 
observed for Huntingtin, the glutamine-rich protein responsible for Huntington’s disease, where 
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the N-terminal α-helical segment, which otherwise do not interact with the polyQ amyloid fibril 
core, greatly accelerates aggregation.63 Furthermore, as PPII helix is an extended conformation 
which overlaps with the allowed region of β-sheet structure64, this conformation could be 
favorable for the conversion of the non-proline residues to the cross-β-sheet structures of 
amyloid fibrils. Blanch and co-workers emphasized the role of PPII structure in the conversion 
of the α-helical human lysozyme into amyloid fibrils.65 Bielska et al. reported that 
hyperphosphorylation of tau induces local polyproline II helix.66 In our earlier theoretical work, 
the formation of PPII structure was predicted to be energetically favorable.62 The present results 
give solid experimental evidence that besides intermolecular β-sheet formation, PPII structure-
based aggregation can also take place. Therefore we suggest an aggregation scheme (depicted in 
Figure 7) which includes all the possible states Trp-cage miniproteins and presumably other 
globular proteins can visit during their conversion from native to aggregated state. 
Recently, investigation of the possible role of phosphorylation in aggregation and amyloidoses 
of α-synuclein, amyloid-β, superoxide dismutase, prion and other proteins emerged into notice 
and outlined the host of far-reaching effects, either on molecular or on cellular levels.19-21,25,67-69
Our results demonstrated that Trp-cage miniproteins are sensitive models for studying the effect 
of phosphorylation on aggregation and amyloid formation, exhibiting highly site-specific effects, 
in some cases facilitating and in others by blocking amyloid fibrillization.
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Figure 7. Schematic representation of the different structures and theoretical pathways exhibited by Trp-
cage miniproteins. The native fold (Tc5b, D9E, D9S) can be destabilized at higher temperature, protein 
concentration and/or by destabilizing modifications (e.g. phosphorylation), resulting in a dynamic and 
mostly disordered conformational ensemble. This dynamic form could be converted into a PPII helical 
polymer, as is the case for D9S(P), before reaching the amyloid state. For other model systems (13S(P), 
14S(P) and 20S(P)) the conformational equilibrium is shifted directly towards the most stable amyloid 
fibrils. Accordingly, all models end in a folding dead-end street as the β-sheet is the thermodynamically 
available most stable structural ensemble.
CONCLUSION
Here, we challenged the stable, α-helix dominated fold of Trp-cage by using high protein 
concentration and applying site-specific modifications: serine phosphorylations. The monomer 
forms of the phosphorylated variants exhibit mostly disordered structures. With the exception of 
D9S(P), all aggregated Trp-cage variants show CD spectra of high β-structure content and 
amide-I IR bands characteristic of intermolecular β-sheets. TEM images revealed the presence of 
highly ordered amyloid-like fibrils of various size and morphology. Their high ThT fluorescence 
verifies an amyloid-like structure. Intriguingly, D9S(P) forms thin fibrils showing a PPII-helix 
type CD spectrum with a negligible ThT binding capacity. Inspired by these new experimental 
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results and structural restraints, our atomic resolution model of D9S(P) aggregate suggests a 
collagen-like polymer form. In summary, Trp-cage miniproteins adopt characteristic 
conformational states like larger proteins do: from a globular structure through highly dynamic 
random coil to ordered amyloid fibrils. The phosphorylation of a single serine residue serves not 
only as a conformational switch between the ordered and unstructured states, but it also 
contributes to the fine-tuning of the intermolecular β-sheet formation via PPII structure-based 
aggregation. Using  the atomic level structural information on Trp-cage folds, one could decipher 
modes of structural transformation of larger proteins from native to amyloid states.
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